For Immediate Release:
New Partnerships Position Suneva Medical as leader in Regenerative Aesthetics.
Suneva Announces the Addition of Two New Innovative Products to their Aesthetics Portfolio
January 3, 2019 (San Diego, CA) — Suneva® Medical, Inc., is proud to announce two exciting new partnerships intended to shape the future of regenerative aesthetics. Building on the success of Bellafill, the company’s flagship brand, first regenerative product and the longest lasting dermal filler on the market, Suneva Medical has signed two new partnerships with Healeon Medical and Bimini Technologies.
“The combination of our world class commercial organization and these unique and innovative Aesthetic products strategically positions us for long term growth,” says Preston Romm, CEO, Suneva Medical. “These new products will add significant breadth to Suneva’s product portfolio.”
Bellafill - Stimulate your patient's own natural collagen and stimulate the growth of your practice.
#1 Patient Need is a Catalyst for Practice Growth.
Research shows 90% of dermal filler patients want an FDA approved 5 year filler. Which means Bellafill can help build loyalty in your practice, because 82% would get other aesthetic treatments from a provider that offered a long-term filler.*
*Harris Poll Survey, 2018
Puregraft - the most predictable fat graft on the market.
64% of fat grafters using unstandardized techniques admit that poor retention is their biggest challenge.*
Puregraft is the most predictable system on the market that has been clinically validated to improve long-term graft retention.
*Source: ASAPS 2014 Fat Grafting Survey
Suneva HD PRP - A PLATFORM TO PROCESS AND CAPTURE OPTIMAL PLATELET CONCENTRATES
With a unqiue gel seperator, Suneva HD PRP system enables providers to get the highest concentration of platelets with the smallest amount of blood draw. With this platform, providers can now prepare 6ml of PRP with the highest concentration of regenerative cells in a quick 6 minute spin.
About Suneva Medical
Suneva Medical, Inc. is a privately‐held aesthetics company focused on and dedicated to developing, manufacturing and commercializing novel, differentiated products for the regenerative aesthetic markets, meeting the high demand of both physicians and patients.
For Further Information
Please use this form to contact Suneva Medical for:
Or contact Gianna Cesa, at Behrman Communications for Media Inquiries. email@example.com 212.986.7000
Medical Affairs Information
To request medical information, please download, print, sign and fax the Medical Information Request Form to (805) 770-3290.
We apologize for any inconvenience you may encounter with our products and request the opportunity to discuss this with you.
We strive to ensure a ositive experience for patients and practice partners and are continuously committed to providing ongoing support programs and special promotions.
US: Bellafill® is indicated for the correction of nasolabial folds and moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years. Bellafill® is also the only dermal filler established safe and effective for the correction of nasolabial folds through 5 years.
Canada: Bellafill® is approved by Health Canada for the correction of facial wrinkles known as nasolabial folds, or smile lines and has been proven safe through 5 years.
Puregraft is certified as a medical device in the European Union under the Medical Device Directive 93/42/EEC by SGS CE0120, exclusively for the indication of autologous fat transfer. Other non-medical uses ascribed to this device such as aesthetic body contouring are not within the scope of CE certification, and users should be aware product performance and/or safety has not been evaluated by SGS for those purposes.
Suneva Medical HD PRP REGULATORY STATUS: FDA-cleared 510(k) Class II medical device. Healeon HD PRP is designed to be used for the safe and rapid preparation of autologous platelet-rich-plasma (PRP) from a small sample of peripheral blood at the patient point of care. The PRP is mixed with autograft and/orallograft bone prior to application to a bony defect for improving handling characteristics.
510(k) number: BK170136